CSF2 and colitis: Commensurate with a central role for GM-CSF in these clinical phenotypes, neutralization with an anti-GM-CSF antibody improved clinical parameters in DSS-induced colitis to a similar extent to that observed with ILC depletion, including reduced weight loss and increased colon length (Figure 2D).